Lexaria Bioscience Corp (LEXX)

[Screech691]

Lower Prices for ViPovaTMTea Due to Production Efficiencies

Kelowna, BC / March 24, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) announces an immediate reduction in price for ViPovaTM CBD-infused tea from US$129 to US$99.

Efficiencies in the production process are allowing us to achieve lower costs, and those savings are being passed on to consumers. The lipid-infusion process is a patent-pending method used to bind the cannabidiol (CBD) with lipids for a more comforting and efficient experience.

Most competitors simply mix raw CBD contained with hemp oil into their edible products, but some studies have indicated that bioabsorption of CBD in this way is very poor. According to a story published February 27 by MainStreet, George Anastassov said “The compounds get destroyed by acid in the gastrointestinal tract, so there’s not much left of the benefits of CBD’s to be delivered to the blood stream. It’s not only about a product containing CBD’s but how much your body absorbs.” ViPova’s patent-pending technology takes a little more time to incorporate into products than competitors who just add raw hemp oil, but in the last several months we have learned how to implement our techniques with greater efficiency and this has led to lower consumer prices.

The www.vipova.com website has already been changed to reflect the new pricing, and the coupon good for 30% off your second order remains in effect.

About Lexaria
Lexaria's shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns. www.lexarienergy.com

About ViPovaTM
ViPovaTM uses only legal CBD oil extracts, grown from legal hemp in locations where it is legal to do so, in ViPovaTM-branded tea. ViPovaTM uses its patent-pending process to infuse concentrated amounts of CBD within lipids in its tea, providing more bioactivity and comfort to the body during the absorption process. Only ViPovaTM has this ground-breaking technology for CBD/lipid infusion. www.vipova.com

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
[phone]